• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, May 14, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Commentary: Modifications to Medicare rules could support care innovation for dialysis

Bioengineer by Bioengineer
April 19, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Considering QOL for end-stage kidney disease patients

ATLANTA –In a commentary published in the American Journal of Kidney Diseases, public health researchers suggest adjustments to recently proposed rule changes on how Medicare pays for dialysis services.

Medicare spends approximately $35 billion annually on care for beneficiaries with end-stage renal disease (kidney failure), more than 7 percent of Medicare’s total paid claims. Over half a million people receive regular dialysis treatments to manage this condition, with treatment costs averaging about $85,000 a year, according to the study.

“A year ago, rule changes were proposed that would limit how many dialysis treatments per week Medicare would pay for,” says first author Adam S. Wilk, PhD. “Nephrologists, patients and other interest groups expressed concern that this would have the effect of limiting dialysis patients’ access to innovations in treatment, like ‘frequent hemodialysis,’ that have the potential to improve outcomes and quality of life in this population.” Wilk is assistant professor of health policy and management at the Emory Rollins School of Public Health.

Under the current system, Medicare covers three hemodialysis treatments weekly per patient, but it will often pay for additional treatments when the treating nephrologist provides sufficient medical justification. The recently proposed rule changes would limit such additional payments to exceptional circumstances (for example, patients with temporary, acute kidney treatment needs). Although nephrologists would not be prevented from providing any “extra” treatments they believe are needed, they would typically bear the costs of doing so.

In their article, Wilk and colleagues discussed the limitations of the current evidence on frequent dialysis treatment, which to date has yielded mixed conclusions. The researchers’ suggested changes to Medicare’s dialysis payment system were designed to account for these limitations and give Medicare the flexibility to further modify the system in the future as new evidence comes to light. Under the most provocative of their proposals, Medicare would establish a new, separate prospective payment system for frequent hemodialysis treatment.

“If Medicare were to adopt the policy options we describe, nephrologists would have greater clarity about how they would be paid for their dialysis care, giving them greater freedom to identify better ways to treat their dialysis patients. Given the poor prognoses most patients undergoing dialysis have, such innovations are greatly needed to improve this population’s longevity and quality of life,” says Wilk.

###

Media Contact
Holly Korschun
[email protected]

Related Journal Article

http://news.emory.edu/stories/2019/04/wilk_dialysis_medicare/index.html
http://dx.doi.org/10.1053/j.ajkd.2019.01.027

Tags: Health CareHealth Care Systems/ServicesInternal MedicineMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Maveropepimut-S Combo Shows Promise in Ovarian Cancer

May 14, 2026

New Global Study Reveals Challenges in Combating High Blood Pressure Effectively

May 13, 2026

Randomised Controlled Trial Finds Semaglutide Effective for Severe Obesity in Long-Term Treatment-Resistant Young Patients

May 13, 2026

Unraveling Dementia Networks in Singapore’s Elderly

May 13, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    842 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    729 shares
    Share 291 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Triple-Negative Breast Cancer Ecotypes and Chemotherapy Response

Maveropepimut-S Combo Shows Promise in Ovarian Cancer

Gaussian Boson Sampling: 1,024 Squeezed States, 8,176 Modes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.